Gufic Biosciences Share Price
Gufic Biosciences Share Price Today
As of 20 Jul 2026, Gufic Biosciences share price is ₹380.35. The stock opened at ₹378.50, compared to its previous close of ₹381.90. During today's trading session, Gufic Biosciences share price moved in the range of ₹378.45 to ₹385.95, with an average price of ₹382.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹268.00 and a high of ₹448.00. On the performance front, Gufic Biosciences share price has increased by 20.80% over the last six months and is down 0.92% on a year-on-year basis.
Gufic Biosciences Returns Calculator
Gufic Biosciences Shareholder Returns
Gufic Biosciences Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,815.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,92,678.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,61,323.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,14,585.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Zydus Lifesciences | 1,13,990.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,11,661.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,896.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 1,01,067.00 | 24.97 | 2.75 | 11.64% | 0.15 | 13.65% | 3.32 | 0.64% | 0.63 | 38.68 |
| Aurobindo Pharma | 89,097.90 | 25.44 | 2.35 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,639.30 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Gufic Biosciences Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Revenue | ₹819.81 | ₹806.67 |
| Other Income | ₹3.63 | ₹2.18 |
| Total Revenue | ₹823.43 | ₹808.84 |
| Total Expenses | ₹729.29 | ₹693.17 |
| Profit Before Tax | ₹94.14 | ₹115.67 |
| Tax | ₹24.49 | ₹29.54 |
| Profit After Tax | ₹69.65 | ₹86.14 |
| EPS - Basic | ₹6.95 | ₹8.74 |
| EPS - Diluted | ₹6.95 | ₹8.74 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Profit before tax | ₹69.65 | ₹86.14 |
| Income before WC changes | ₹137.94 | ₹149.82 |
| Change in Assets | -₹9.02 | -₹170.27 |
| Change in Liabilities | ₹16.46 | ₹40.04 |
| Change in WC | ₹7.44 | -₹130.23 |
| Cash flow from Operations | ₹122.57 | -₹7.46 |
| Cash flow from Investing | -₹70.78 | -₹102.39 |
| Cash flow from Financing | -₹37.20 | ₹82.38 |
| Total Cash Flow | ₹14.59 | -₹27.47 |
| Cash (Start of the year) | ₹1.14 | ₹28.60 |
| Cash (End of the year) | ₹15.72 | ₹1.14 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Non-Current Assets | ₹544.84 | ₹492.06 |
| Current Assets | ₹624.52 | ₹600.48 |
| Total Assets | ₹1,169.36 | ₹1,092.54 |
| Current Liabilities | ₹387.56 | ₹372.05 |
| Net Current Asset | ₹236.97 | ₹228.43 |
| Non-Current Liabilities | ₹180.73 | ₹187.93 |
| Equity Capital | ₹601.08 | ₹532.56 |
| Total Equity & Liabilities | ₹1,169.36 | ₹1,092.54 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹819.81 | ₹806.67 | ₹690.62 | ₹779.16 |
| Other Income | ₹3.62 | ₹2.18 | ₹2.57 | ₹3.10 |
| Total Revenue | ₹823.42 | ₹808.84 | ₹693.19 | ₹782.26 |
| Total Expenses | ₹728.99 | ₹693.17 | ₹586.47 | ₹655.42 |
| Profit Before Tax | ₹94.43 | ₹115.67 | ₹106.72 | ₹126.84 |
| Tax | ₹24.49 | ₹29.54 | ₹27.02 | ₹31.00 |
| Profit After Tax | ₹69.93 | ₹86.14 | ₹79.70 | ₹95.84 |
| EPS - Basic | ₹6.97 | ₹8.74 | ₹8.22 | ₹9.89 |
| EPS - Diluted | ₹6.97 | ₹8.74 | ₹8.22 | ₹9.89 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹69.93 | ₹86.14 | ₹79.70 | ₹95.84 |
| Income before WC changes | ₹138.22 | ₹149.82 | ₹136.36 | ₹150.02 |
| Change in Assets | -₹9.08 | -₹170.27 | -₹123.21 | -₹44.36 |
| Change in Liabilities | ₹16.44 | ₹40.04 | -₹12.05 | ₹33.64 |
| Change in WC | ₹7.37 | -₹130.23 | -₹135.25 | -₹10.72 |
| Cash flow from Operations | ₹122.78 | -₹7.46 | -₹26.59 | ₹106.24 |
| Cash flow from Investing | -₹71.79 | -₹102.40 | -₹190.73 | -₹94.59 |
| Cash flow from Financing | -₹37.20 | ₹82.38 | ₹234.31 | -₹6.24 |
| Total Cash Flow | ₹13.78 | -₹27.48 | ₹16.99 | ₹5.41 |
| Cash (Start of the year) | ₹1.13 | ₹28.60 | ₹11.61 | ₹6.20 |
| Cash (End of the year) | ₹14.91 | ₹1.13 | ₹28.60 | ₹11.61 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹545.85 | ₹492.07 | ₹397.05 | ₹200.65 |
| Current Assets | ₹623.78 | ₹600.47 | ₹464.11 | ₹320.75 |
| Total Assets | ₹1,169.63 | ₹1,092.54 | ₹861.16 | ₹521.40 |
| Current Liabilities | ₹387.53 | ₹372.05 | ₹288.21 | ₹186.40 |
| Net Current Asset | ₹236.24 | ₹228.42 | ₹175.90 | ₹134.35 |
| Non-Current Liabilities | ₹180.73 | ₹187.93 | ₹225.14 | ₹65.88 |
| Equity Capital | ₹601.36 | ₹532.56 | ₹347.81 | ₹269.12 |
| Total Equity & Liabilities | ₹1,169.63 | ₹1,092.54 | ₹861.16 | ₹521.40 |
About Gufic Biosciences
Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates in the pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.
Gufic Biosciences Financial Highlights
- Revenue: Gufic Biosciences reported revenue of ₹946.67 crore in FY26 vs ₹823.44 crore in FY25. It showed an increase of 14.97% on a yearly basis.
- Operating Profit: Gufic Biosciences reported an operating profit of ₹86.55 crore in FY26 vs ₹94.14 crore in FY25. It showed a decrease of 8.06% on a year-on-year basis.
- Net Profit: Gufic Biosciences reported a net profit of ₹64.21 crore in FY26 vs ₹69.65 crore in FY25. It showed a decrease of 7.81% on a yearly basis.
Gufic Biosciences Quarterly Result Highlights
- Gufic Biosciences reported revenue of ₹250.65 crore in Mar 2026, compared with ₹232.20 crore in Dec 2025, representing an increase of 7.95% on a quarter-on-quarter (QoQ) basis.
- Gufic Biosciences reported an operating profit of ₹28.95 crore in Mar 2026, compared with ₹17.72 crore in Dec 2025, representing an increase of 63.37% on a quarter-on-quarter (QoQ) basis.
- Gufic Biosciences reported a profit of ₹21.90 crore in Mar 2026, compared with ₹12.42 crore in Dec 2025, reflecting an increase of 76.33% on a QoQ basis.
- The earnings per share (EPS) of Gufic Biosciences stood at ₹6.95 during Mar 2026.
Similar Stocks
FAQs on Gufic Biosciences Share Price
What is Gufic Biosciences share price today?
Gufic Biosciences share price is ₹380.35 as on 20 Jul, 2026, 11:07 IST.
How has the Gufic Biosciences share price performed in the past?
In the last 1 year, Gufic Biosciences delivered a return of -0.92%. The Gufic Biosciences share price hit a high of ₹448.00 and low of ₹268.00.
How much is the Mutual Fund shareholding in Gufic Biosciences shares?
The Mutual Fund Shareholding in Gufic Biosciences was 3.63% at the end of Mar 2026.
What is the the 52-week high and low of Gufic Biosciences shares ?
The 52-week high and low of Gufic Biosciences share is ₹448.00 and ₹268.00 as of 20 Jul, 2026.
What is the market cap of Gufic Biosciences?
The market capitalisation of Gufic Biosciences is ₹3,826.78 Crores as on 20 Jul, 2026.
What are the stock symbols of Gufic Biosciences?
The stock symbol of Gufic Biosciences is GUFICBIO on the NSE, 509079 on the BSE, and the ISIN is INE742B01025.
What was yesterday's closing price of Gufic Biosciences shares ?
Gufic Biosciences shares closed yesterday at ₹381.90 on NSE & ₹381.60 on BSE
How to buy Gufic Biosciences shares?
To buy Gufic Biosciences shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Gufic Biosciences shares on Holidays?
No, shares of Gufic Biosciences or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Gufic Biosciences shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Gufic Biosciences?
The PE and PB ratio of Gufic Biosciences is 59.63 and 5.76 respectively, as on 20 Jul, 2026, 11:07 IST.